The stock market is on the cusp of a significant breakout, and we detail the eight stocks that may lead the way higher in the coming weeks.
It’s September, and the chase for performance is on as investors flock into some of the hottest stocks around. We give you 17 that may have a monster final four months.
Biotechs are getting close to a big breakout, we show you 5 that may lead the charge higher. Plus a look at Amazon, Intel, and TI
The Stock Market Is A Battle of Good and Bad As Uncertainty Runs Wild MICHAEL KRAMER OWNS XLF PUTS Michael Kramer and the clients of Mott Capital own shares of NXPI Stocks continued the see-saw action today we have seen for most of 2018. I think the Fed minutes today demonstrate rather well why there … Read more
Facebook, Alphabet, Tesla, Intel, Biogen, Gilead, Oil – The Daily Rundown June 18 MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN SHARES OF TSLA AND GOOGL The stock market had another back and forth session with the S&P 500 trading lower on the day, but it was Technology, Energy, and Biotech that finished the day … Read more
Amazon’s Stock Nears Big Break Out, While Micron’s Stock Gets Crushed michael kramer and the clients of mott capital own shares of googl Stocks continue to churn, with the S&P 500 down about 70 bps today, giving up some the gains from yesterday. But as we noted yesterday, there is a clear rotation going on … Read more
Biotech Stocks May Have Finally Been Unleashed Michael Kramer and the Clients of Mott Capital Own CELG Stocks continued to move higher, led by the Biotech’s, which were up by about 3 percent. There’s something we haven’t said in a long time. The highly anticipated speech regarding drug prices by the President didn’t seem to … Read more
Biotech and Tech Stocks Are Approaching Make Or Break Moments The stock market picked right up from where it left off last week, with the S&P 500 continuing to surging to 2,721 up about 1.1 percent today. Based on the charts, it seems like we have a pretty good shot of continuing to rise to somewhere between … Read more
Biotech Stocks Continue To Soar, More Gains To Come Biotech stocks continue to soar, and Biogen and Gilead had big days on Friday. Biogen jumped by nearly 4 percent, taking shares up $368, after reporting robust result on Thursday. Gilead shares jumped by over 5 percent, to over $85, after getting an upgrade from Jefferies and … Read more
Why Biotech Stocks Will Continue To Reach Record Heights Biotech stocks continue to rip higher, with the S&P Biotech ETF ($XBI) reaching a new record high, and the Nasdaq Biotech ETF ($IBB) quickly running to $122. The XBI is now up by over 12 percent on the year, while the IBB is up about 10 … Read more
Under Armour, Bitcoin, AMD, Biogen, Gilead, Pfizer – Monster Commentary S&P 500 The S&P 500 had a relatively uneventful day, with the index finishing the day down less than 20 bps. But the thing to take note of is how the index has now failed right at 2,805 three times. Big deal? Likely not, and … Read more
Stock Market Sells Off As Biotech Gets Rocked, Again! Just more of the same isn’t? Gap up at the open, then a slow drag lower the rest of the day. I hate days were the market just gaps up, what is the point? It always just fills the gap. You must avoid opens like the one … Read more
Facebook’s Big Fall, Plus Is Tesla The Next Apple? – The Week Ahead Earnings will start trickling out this week with companies like Goldman Sachs ($GS), IBM ($IBM) and Procter& Gamble ($PG), but the full slate of earnings don’t start until the week of January 22. So we should just see a continuation of this … Read more
Bitcoin, AMD, Nvidia, Biotech, Could Apple iPhone Worries Be Overblown It is a new year, and with that everything gets reset back to zero, but other than not much else should change when trading opens again on January 2. Bitcoin It seems likely Bitcoin will continue its decline as well. In an Investopedia article on … Read more